Professor, Indiana University School of Medicine
Dirección de correo verificada de
Citado por
Citado por
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently
M Leid, P Kastner, R Lyons, H Nakshatri, M Saunders, T Zacharewski, ...
Cell 68 (2), 377-395, 1992
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance
RA Campbell, P Bhat-Nakshatri, NM Patel, D Constantinidou, S Ali, ...
Journal of Biological Chemistry 276 (13), 9817-9824, 2001
CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
C Sheridan, H Kishimoto, RK Fuchs, S Mehrotra, P Bhat-Nakshatri, ...
Breast Cancer Research 8, 1-13, 2006
Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
H Nakshatri, P Bhat-Nakshatri, DA Martin, RJ Goulet Jr, GW Sledge Jr
Molecular and cellular biology 17 (7), 3629-3639, 1997
NF-κ B promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4
G Helbig, KW Christopherson, P Bhat-Nakshatri, S Kumar, H Kishimoto, ...
Journal of biological chemistry 278 (24), 21631-21638, 2003
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
HL Chua, P Bhat-Nakshatri, SE Clare, A Morimiya, S Badve, H Nakshatri
Oncogene 26 (5), 711-724, 2007
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production
T Starnes, MJ Robertson, G Sledge, S Kelich, H Nakshatri, HE Broxmeyer, ...
The Journal of Immunology 167 (8), 4137-4140, 2001
RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo.
S Nagpal, S Friant, H Nakshatri, P Chambon
The EMBO journal 12 (6), 2349-2360, 1993
Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors
S Nagpal, M Saunders, P Kastner, B Durand, H Nakshatri, P Chambon
Cell 70 (6), 1007-1019, 1992
Estradiol-regulated microRNAs control estradiol response in breast cancer cells
P Bhat-Nakshatri, G Wang, NR Collins, MJ Thomson, TR Geistlinger, ...
Nucleic acids research 37 (14), 4850-4861, 2009
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide
NM Patel, S Nozaki, NH Shortle, P Bhat-Nakshatri, TR Newton, S Rice, ...
Oncogene 19 (36), 4159-4169, 2000
PROGgeneV2: enhancements on the existing database
CP Goswami, H Nakshatri
BMC cancer 14, 1-6, 2014
FOXA1 expression in breast cancer—correlation with luminal subtype A and survival
S Badve, D Turbin, MA Thorat, A Morimiya, TO Nielsen, CM Perou, ...
Clinical cancer research 13 (15), 4415-4421, 2007
A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter.
WC Smith, H Nakshatri, P Leroy, J Rees, P Chambon
The EMBO journal 10 (8), 2223-2230, 1991
Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element.
P Leroy, H Nakshatri, P Chambon
Proceedings of the National Academy of Sciences 88 (22), 10138-10142, 1991
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells
R Hromas, HE Broxmeyer, C Kim, H Nakshatri, K Christopherson II, ...
Biochemical and biophysical research communications 255 (3), 703-706, 1999
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer
CJ Sweeney, S Mehrotra, MR Sadaria, S Kumar, NH Shortle, Y Roman, ...
Molecular cancer therapeutics 4 (6), 1004-1012, 2005
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
E Resetkova, JS Reis-Filho, RK Jain, R Mehta, MA Thorat, H Nakshatri, ...
Breast cancer research and treatment 123, 97-108, 2010
Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
C Sweeney, L Li, R Shanmugam, P Bhat-Nakshatri, V Jayaprakasan, ...
Clinical Cancer Research 10 (16), 5501-5507, 2004
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24-phenotype
P Bhat-Nakshatri, H Appaiah, C Ballas, P Pick-Franke, R Goulet, S Badve, ...
BMC cancer 10, 1-16, 2010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20